The Penn State Clinical and Translational Science Institute (CTSI) can provide a wide range of consultation services during all stages of studies, and specifically during the project development and start-up phases. See CTSI consultation services:

The Penn State Research Portal (PURE) is a publicly-available system that captures and displays the research output of the University, both for investigators and units, and facilitates collaboration between investigators across the University and beyond. Pure aggregates research information from internal and external sources and enhances the visibility and discoverability of research at Penn State, both internally and externally.

All investigators who are engaged in research must complete Penn State University’s required Financial Conflict of Interest (FCOI) training and submit a disclosure of significant financial interest.

Penn State uses the Collaborative Institutional Training Initiative (CITI) program to offer content that fulfills that human subjects research training requirement for IRB approval. The CITI human subjects training includes a required module on HIPAA privacy and security that fulfills HIPAA training for investigators human subjects research. Click here to begin training in CITI.

Some studies defined as "clinical research" or a "clinical trial" have special compliance requirements. For compliance purposes, there are three definitions of clinical trials depending on the funding or regulatory oversight. Studies with NIH funding follow the Common Rule definition, which is a similar definition used by other federal funding agencies. FDA-regulated research defines a clinical trial as research meeting the criteria of an "applicable clinical trials" (ACT).

Penn State has a number of policies relevant to clinical research. Research protections policies include: